EUVIMEDEUVIMED entdecken
Leitlinie

ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins

Jing Cao iD, Leslie Donato, Joe M El-Khoury iD, Anne Goldberg, Jeffrey W Meeusen, Alan T Remaley

The Journal of Applied Laboratory Medicine · 03.09.2024 · 9 (5) · 1040-1056

DOI: 10.1093/jalm/jfae057 ↗

Kurz gefasst

Leitlinie in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 03.09.2024. Verfasst von Jing Cao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States. Hauptthemen laut MEDLINE: Lipoproteins, Lipids. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The accurate measurement of blood lipids and lipoproteins is crucial for the clinical management of atherosclerotic disease risk. Despite progress in standardization, there are still significant variations in pre-analytical requirements, methods, nomenclature, and reporting work flows. Content The guidance document aims to improve standardization of clinical lipid testing work flows. It provides recommendations for the components of the lipid panel, fasting requirements, reporting of results, and specific recommendations for non-high-density lipoprotein cholesterol (non-HDL-C), low-density lipoprotein cholesterol (LDL-C), lipoprotein(a) [Lp(a)], apolipoprotein B (apo B), point-of-care lipid testing, and LDL subfraction testing. Summary Lipid panels should always report non-HDL-C and LDL-C calculations if possible. Fasting is not routinely required except in specific cases. Modern equations should be utilized for LDL-C calculation. These equations allow for LDL-C reporting at elevated concentrations of triglycerides and obviate the need for direct measured LDL-C in most cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoproteinsLipidsHumansCholesterol, LDLApolipoproteins BAtherosclerosisLipoprotein(a)

Substanzen

LipoproteinsLipidsCholesterol, LDLApolipoproteins BLipoprotein(a)

Autor:innen und Institutionen

  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, United States.
  • Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, United States.
  • Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.

ORCID-Profile: Jing Cao, Joe M El-Khoury

Zitieren

APA

Cao, J., Donato, L., El-Khoury, J. M., Goldberg, A., Meeusen, J. W., & Remaley, A. T. (2024). ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins. The Journal of Applied Laboratory Medicine, 9(5), 1040-1056. https://doi.org/10.1093/jalm/jfae057

Vancouver

Cao J, Donato L, El-Khoury JM, Goldberg A, Meeusen JW, Remaley AT. ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins. The Journal of Applied Laboratory Medicine. 2024;9(5):1040-1056. doi:10.1093/jalm/jfae057

BibTeX
@article{Cao2024,
  author = {Cao, Jing and Donato, Leslie and El-Khoury, Joe M and Goldberg, Anne and Meeusen, Jeffrey W and Remaley, Alan T},
  title = {ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2024},
  volume = {9},
  number = {5},
  pages = {1040--1056},
  doi = {10.1093/jalm/jfae057}
}
Kostenlos starten →